Dmitry Zamoryakhin
Chief Tech/Sci/R&D Officer en BIODEXA PHARMACEUTICALS PLC .
Perfil
Dmitry Zamoryakhin is currently the Chief Scientific Officer at Biodexa Pharmaceuticals Plc since 2021.
Prior to this, he worked as the Chief Medical Officer at Oxford Biomedica Plc from 2018 to 2021 and as the Head-Development Strategy & Intelligence at Grünenthal GmbH from 2016 to 2018.
Dr. Zamoryakhin holds an MBA and a doctorate from Warwick Business School and a doctorate from Perm State Medical University.
Cargos activos de Dmitry Zamoryakhin
| Empresas | Cargo | Inicio |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 11/07/2021 |
Antiguos cargos conocidos de Dmitry Zamoryakhin.
| Empresas | Cargo | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Corporate Officer/Principal | 01/08/2018 |
Formación de Dmitry Zamoryakhin.
| Warwick Business School | Doctorate Degree |
| Perm State Medical University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Dmitry Zamoryakhin
